Lightnews — Scholar-powered news

EFMC

@euromedchem.bsky.social

340 followers 140 following 87 posts

The official feed of the European Federation for Medicinal chemistry and Chemical biology.

Posts Media Videos Starter Packs

Pinned

EFMC @euromedchem.bsky.social · Dec 3

💙 We've officially moved to Bluesky! 💙

While we’ve loved connecting with you on X/Twitter, it's time for a fresh start in a platform that aligns with our values & vision.

Join the conversation & stay updated with all things EFMC. Let’s build an inclusive and sustainable community together.

2 18

EFMC @euromedchem.bsky.social · 4d

Academia is tough — burnout, imposter syndrome, and the pressure to publish can be overwhelming. 💭

Join us on Oct 10, 1PM for Under Pressure, a free virtual workshop on mental health in academia.

🎙 Lashuel, Cahill & Ho
👉 Register: www.efmc.info/mental-healt...

EFMC @euromedchem.bsky.social · 5d

Don't miss out on the EFMC² Tandem Talks where Hans Matter and Maria Méndez Pérez (Sanofi) will discuss Modern Computational Design Meets Late-Stage Functionalization: A New Class of RIPK1 Inhibitor.

📅 October 9 - 4 PM
🔗 buff.ly/1jaKQAQ

EFMC @euromedchem.bsky.social · 13d

Join us for "Under Pressure: A Mental Health Conversation for the Academic Community," a virtual workshop to build resilience, support, and a healthier future in academia.

📅 October 10 - 1PM
🔗 buff.ly/CiXa7F8

Complete our anonymous survey to shape the discussion.
📝 buff.ly/H2NmBru

EFMC @euromedchem.bsky.social · 18d

🖥️ MedChemBio Posters Online is coming back !

📆 The event will take place on LinkedIn on November 20, 2025, from 10 AM to 6 PM CET. It’s open to any young researchers worldwide, whether from academia or industry.

▶️ More info & Registration on: buff.ly/4j57fID

EFMC @euromedchem.bsky.social · 20d

📃 EFMC Literature Spotlight 📃

This edition’s contribution provided by Massimiliano Runfola (University of Oxford, United Kingdom)“Identification of a New Interesting BAG3 Modulator Able to Disrupt Cancer-Related Pathways” by Dafne Ruggiero et al. (ChemMedChem 2025)

Identification of a New Interesting BAG3 Modulator Able to Disrupt Cancer‐Related Pathways

Compound 2, identified through in-house screening and derived from SP18, exhibits high affinity for BAG3, as demonstrated by Surface Plasmon Resonance and docking studies. It induces a…

buff.ly

EFMC @euromedchem.bsky.social · 20d

👩‍🔬 Have you read our latest #MedChemBioConversation ?

Get to know Gavriil Efthymios from Imperial College London, UK.🔍
Dive into our monthly talks with specialists to explore the latest breakthroughs in drug discovery and pick up some valuable advice.

🔗https://buff.ly/JgcwZqf

EFMC @euromedchem.bsky.social · 23d

📢 The 3rdnd Lunch & Learn session is coming!

Join us to explore "Direct-to-Biology Platforms to Accelerate Drug Discovery" with Dr Rebecca Stevens, Andreas Holmqvist and Dr Cassie Pratley.

📅 Oct 14, 13:00 CET.
🔗https://buff.ly/xpMDjcN

#DrugDiscovery

EFMC @euromedchem.bsky.social · 24d

📰The September issue of MedChemBioWatch has arrived!📰

Check out our newest newsletter edition, uncover our latest updates, and ensure you're up-to-date with our forthcoming events.

EFMC @euromedchem.bsky.social · Sep 11

The schedule is out!

Join Hans Matter and Maria Méndez Pérez from Sanofi to discuss "Modern Computational Design Meets Late-Stage Functionalization: A New Class of RIPK1 Inhibitors." Tim Knehans will showcase how Schrödinger aids life science innovation.

📅 October 9 - 4pm
🔗 buff.ly/KINI5tx

EFMC @euromedchem.bsky.social · Sep 4

Strong start to the final day of EFMC-ASMC 2025! Dr Jesus Alcazar (J&J) on flow automation for drug discovery, followed by inspiring work from Prof. Paula Gomes (University of Porto) on Nobel-prized chemistries for new therapies.

EFMC @euromedchem.bsky.social · Sep 4

Kicking off the last day of EFMC-ASMC 2025!

EFMC @euromedchem.bsky.social · Sep 3

Excellent talk this afternoon by Dr Rebecca Ebenhoch (Boehringer Ingelheim) on the power of cEM to enable structure-based drug design for membrane targets.

EFMC @euromedchem.bsky.social · Sep 3

A new day of knowledge has officially begun with the first talk of the day: Dr Matthew Woll (PTC Therapeutics) on Therapeutic Splice Modifiers.

EFMC @euromedchem.bsky.social · Sep 2

Great science this afternoon at EFMC-ASMC 2025! Dr Thomas Cummins (BMS) presented exciting work on a first-in-class molecular glue degrader for sickle cell disease, followed by Dr Emanuela Berrino (CEA Paris-Saclay) with excellent insights into fluorescent nanoparticles for multiplexed immunoassays.

EFMC @euromedchem.bsky.social · Sep 2

A strong start to Day 2 of EFMC-ASMC 2025!

Prof. Dirk Trauner (UPenn) opened the morning with excellent insights into photopharmacology, followed by essencial work from Dr Luke Ashcraft (Cytokinetics) on novel cardiac myosin inhibitors for HFpEF.

EFMC @euromedchem.bsky.social · Sep 1

Fantastic session with Prof. Annemieke Madder (UGent) presenting an excellent perspective on the power of large peptides and “gigantic” bioconjugates in targeted therapy.

EFMC @euromedchem.bsky.social · Sep 1

Great keynote by Prof. Paolo Melchiorre (University of Bologna) on The Synergy of Light, Organocatalysis & Enzymes.

EFMC @euromedchem.bsky.social · Sep 1

First talk of the day: Prof. Helma Wennemers (ETH Zurich) on Asymmetric Peptide Catalysis.

EFMC @euromedchem.bsky.social · Aug 31

Kicking off EFMC-ASMC 2025! 🎉 Opening Ceremony with Dr Malin Lemurell, Prof. Nuno Maulide and Dr Luc Van Hijfte.

Excellent opening keynote by Prof. Samuel Stupp on “Supramolecular Peptide Therapeutics: A New Frontier for Regeneration”.

2 4

EFMC @euromedchem.bsky.social · Aug 28

📢 Join the 6th EFMC² Tandem Talk!

Maria Méndez Pérez and Hans Matter from Sanofi will discuss Modern Computational Design Meets Late-Stage Functionalization: A New Class of RIPK1 Inhibitors.

Free and open to all, thanks to Schrödinger.

📆 October 9 | 16:00-17:00 CET
🔗 buff.ly/L3NXc0E

EFMC @euromedchem.bsky.social · Aug 27

👩‍🔬 Have you read our latest #MedChemBioConversation ?

Get to know Maria Letizia Barreca from University of Perugia, Italy.🔍
Dive into our monthly talks with specialists to explore the latest breakthroughs in drug discovery and pick up some valuable advice.

🔗https://buff.ly/63Jy5As

2 2

EFMC @euromedchem.bsky.social · Aug 14

📢 The 2nd Lunch & Learn session is coming!

Join us to explore "Protein Kinases as Drug Targets" with Dr. Ricardo Serafim, Ms. Elena Caballero Sánchez, and MSc. Marta Durán Martínez.

📅 Sep 11, 13:00 CET.
🔗https://buff.ly/wptBMwa

#DrugDiscovery #KinaseResearch

EFMC @euromedchem.bsky.social · Aug 7

📃 EFMC Literature Spotlight 📃

This edition’s contribution provided by Dr Maria Korpidou focuses on the recently published article "Development of a Peptide Inhibitor Targeting the C-SH2 Domain of the SHP2 Phosphatase" by Azin Kiani et al., published in ChemBioChem

More at: buff.ly/vzNwmxh

EFMC @euromedchem.bsky.social · Aug 5

📰The August issue of MedChemBioWatch has arrived!📰

Check out our newest newsletter edition, uncover our latest updates, and ensure you're up-to-date with our forthcoming events.

1 1

EFMC @euromedchem.bsky.social · Jul 16

📖 EFMC Literature Spotlight

This edition’s contribution provided by Noemí Martínez Conde focuses on the recently published article “Advancing the Exploration of the Ubiquitin-like Protein FUBI with Synthetic Chemical Tools” by Francesca D’Amico, et al.

🔗Link: buff.ly/cjMWPGn